News

After selling off a portion of its diabetes care business last year, Ypsomed is now fully exiting the diabetes care business ...
Ypsomed announced today that it agreed to sell its diabetes care business to TecMed for up to approximately $517.7 million ...
Medtronic has secured a green light from the FDA to connect its latest automated insulin pump with its newest continuous ...
Medtronic (NYSE:MDT) announced that the FDA approved its Simplera Sync continuous glucose monitor for use with the.
When the Central Board of Secondary Education (CBSE) recently premitted students with Type 1 diabetes to carry glucometers and insulin pumps inside exam halls-- it brought the often-overlooked ...
IRS acting head ousted after US Treasury chief wins power struggle with Musk, NYT reports I toured an Air Force One plane used by 4 US presidents. Take a look inside the 'flying Oval Office.' IRS ...
School Closed As Emergency Alert Issued 13 Best Anti-Inflammatory Dinners for Insulin Resistance Kevin O'Leary on EU willing to go zero-for-zero on tariffs: 'This is the opportunity, this is the ...
Insulin overdose symptoms can include confusion, fatigue, irritability, shaking, and other signs of low blood sugar (hypoglycemia). If you accidentally take too much or your blood sugar is low for ...
Pacemakers. Insulin pumps. Hearing aids. These are just some of the basic medical devices that hospitals and patients rely on—and that could see higher prices due to President Trump’s tariffs.
Types of insulin include rapid-, regular-, intermediate-, and long-acting, based on how long they take to start working. You may take a combination of these when managing type 2 diabetes.
Ways to lower your blood sugar quickly include injecting insulin, taking a missed diabetes medication, exercising, and more. When you have type 1 or type 2 diabetes, dangerous spikes in blood glucose ...
Longtime specialty market closing after decades in CT. ‘This wasn’t an easy decision,’ owners say. Longtime specialty market closing after decades in CT. 'This wasn’t an easy decision ...